EA200300567A1 - TREATMENT OF THE ALARM CONDITIONS - Google Patents

TREATMENT OF THE ALARM CONDITIONS

Info

Publication number
EA200300567A1
EA200300567A1 EA200300567A EA200300567A EA200300567A1 EA 200300567 A1 EA200300567 A1 EA 200300567A1 EA 200300567 A EA200300567 A EA 200300567A EA 200300567 A EA200300567 A EA 200300567A EA 200300567 A1 EA200300567 A1 EA 200300567A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
alarm conditions
published
search report
international search
Prior art date
Application number
EA200300567A
Other languages
Russian (ru)
Inventor
Холли Рид Томассон
Дэвид Михелсон
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200300567A1 publication Critical patent/EA200300567A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Abstract

Селективные ингибиторы вторичного захвата норэпинефрина применяют для лечения состояний тревоги, в особенности обсессивно-компульсивного состояния.Отчет о международном поиске был опубликован 2003.12.24.Selective norepinephrine secondary seizure inhibitors are used to treat anxiety states, especially obsessive-compulsive state. The international search report was published 2003.12.24.

EA200300567A 2000-11-15 2001-11-06 TREATMENT OF THE ALARM CONDITIONS EA200300567A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24901000P 2000-11-15 2000-11-15
US26536201P 2001-01-31 2001-01-31
PCT/US2001/027801 WO2002040006A2 (en) 2000-11-15 2001-11-06 Treatment of anxiety disorders

Publications (1)

Publication Number Publication Date
EA200300567A1 true EA200300567A1 (en) 2004-10-28

Family

ID=26939750

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300567A EA200300567A1 (en) 2000-11-15 2001-11-06 TREATMENT OF THE ALARM CONDITIONS

Country Status (16)

Country Link
EP (1) EP1395253A2 (en)
JP (1) JP2004529073A (en)
KR (1) KR20030051812A (en)
CN (1) CN1822825A (en)
AU (1) AU2002217757A1 (en)
BR (1) BR0115301A (en)
CA (1) CA2426069A1 (en)
CZ (1) CZ20031339A3 (en)
EA (1) EA200300567A1 (en)
HR (1) HRP20030384A2 (en)
IL (1) IL155874A0 (en)
MX (1) MXPA03004190A (en)
NO (1) NO20032156L (en)
PL (1) PL366119A1 (en)
SK (1) SK5422003A3 (en)
WO (1) WO2002040006A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002070457A1 (en) * 2001-03-06 2002-09-12 Eli Lilly And Company Inhibitor of monoamine uptake
AU2003261185A1 (en) * 2002-08-14 2004-03-03 Pharmacia & Upjohn Company Llc Use of reboxetine for the treatment of hot flashes
GB0309440D0 (en) * 2003-04-25 2003-06-04 Lilly Co Eli Quinolone derivatives
WO2004103356A2 (en) * 2003-05-15 2004-12-02 Eli Lilly And Company Treatment of emotional dysregulation
WO2005060949A2 (en) * 2003-12-12 2005-07-07 Eli Lilly And Company Selective norepinephrine reuptake inhibitors for the treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
US8440724B2 (en) 2008-01-09 2013-05-14 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
WO2011056773A2 (en) * 2009-11-03 2011-05-12 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
WO2011056788A2 (en) * 2009-11-03 2011-05-12 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
US9944618B2 (en) 2013-03-14 2018-04-17 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2931997A (en) * 1996-05-07 1997-11-26 Merck & Co., Inc. Treatment of mood disorders with a growth hormone secretagogue
IT1305322B1 (en) * 1998-04-23 2001-05-04 Pharmacia & Upjohn Spa Use of reboxetine for treating obsessive compulsive disorder and panic disorder
KR100935277B1 (en) * 1999-07-01 2010-01-06 파마시아 앤드 업존 캄파니 엘엘씨 Highly Selective Norepinephrine Reuptake Inhibitors and Methods of Using the Same

Also Published As

Publication number Publication date
WO2002040006A3 (en) 2003-12-24
CZ20031339A3 (en) 2003-10-15
KR20030051812A (en) 2003-06-25
EP1395253A2 (en) 2004-03-10
PL366119A1 (en) 2005-01-24
SK5422003A3 (en) 2003-12-02
AU2002217757A1 (en) 2002-05-27
CN1822825A (en) 2006-08-23
CA2426069A1 (en) 2002-05-23
HRP20030384A2 (en) 2003-08-31
JP2004529073A (en) 2004-09-24
BR0115301A (en) 2004-12-14
MXPA03004190A (en) 2003-09-22
IL155874A0 (en) 2003-12-23
NO20032156D0 (en) 2003-05-13
NO20032156L (en) 2003-05-13
WO2002040006A2 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
EA200300171A1 (en) CYCLOPENTANOINDOLS, COMPOSITIONS CONTAINING THE COMPONENTS, AND METHODS OF TREATMENT
EA200201214A1 (en) SUBSTITUTED THYOCETAMIDES
EA200000351A1 (en) TREATMENT OF CONDUCTIVE VIOLATIONS
EA200300906A1 (en) NEW SPYROTRICYCLIC DERIVATIVES AND THEIR APPLICATION AS PHOSPHODESTERASE-7 INHIBITORS
EA200300105A1 (en) Nonsteroid Inflammation Inhibitors
DE60218493D1 (en) SUBSTITUTED 7-AZA-Ä2.2.1ÜBICYCLOHEPTANE FOR THE TREATMENT OF DISEASES
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
EA200300836A1 (en) DERIVATIVES OF PHTHALASINON-PIPERIDINE AS PDE4 INHIBITORS
EA200201252A1 (en) Compounds effective as agonists of e2 - adrenoreceptor and inhibitors of phosphodiesterrase pde4
EA200301276A1 (en) NEW SULPHONIC ACID DERIVATIVES
DE60231107D1 (en) TETRAHYDRO-PYRAZINOÄ1,2-AÜINDOLE FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
EA200300567A1 (en) TREATMENT OF THE ALARM CONDITIONS
MXPA02009313A (en) Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides.
RS51003B (en) A piridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
DE60325377D1 (en) MOTILIDVERBINDUNGEN
DE60033809D1 (en) INHIBITORS OF METAL PROTEINASES
MY136367A (en) Treatment of cognitive failure
DK1438034T3 (en) Use of -phenyl-3-dimethylaminiopropane compounds in the treatment of urinary incontinence
EA200200798A1 (en) CALCYLYTIC COMPOUNDS
DK1161239T3 (en) 3-Cyclopropylmethoxy-4-difluoromethoxy-N- (3,5-dichloropyrid-4-yl) benzamide for the treatment of disseminated sclerosis
ATE403422T1 (en) SUBSTITUTED HYDRAZONE AS AN INHIBITOR OF CYCLOOXYGENASE-2
DK1455770T3 (en) Use of norepinephrine uptake inhibitors for the treatment of tic disorders
DE60133596D1 (en) S-methyl-dihydro-ziprasidone for the treatment of schizophrenia
DK1368023T3 (en) Use of buprenoprphine to treat urinary incontinence
ATE357441T1 (en) SUBSTITUTED 2-PYRROLIDINE-2-YL-1H-INDOLE DERIVATIVE FOR THE TREATMENT OF MIGRAINE